Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9040837rdf:typepubmed:Citationlld:pubmed
pubmed-article:9040837lifeskim:mentionsumls-concept:C0024299lld:lifeskim
pubmed-article:9040837lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:9040837lifeskim:mentionsumls-concept:C1280551lld:lifeskim
pubmed-article:9040837lifeskim:mentionsumls-concept:C0003993lld:lifeskim
pubmed-article:9040837lifeskim:mentionsumls-concept:C0010583lld:lifeskim
pubmed-article:9040837lifeskim:mentionsumls-concept:C0013089lld:lifeskim
pubmed-article:9040837lifeskim:mentionsumls-concept:C0032952lld:lifeskim
pubmed-article:9040837lifeskim:mentionsumls-concept:C0042679lld:lifeskim
pubmed-article:9040837lifeskim:mentionsumls-concept:C0868928lld:lifeskim
pubmed-article:9040837lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:9040837lifeskim:mentionsumls-concept:C0332283lld:lifeskim
pubmed-article:9040837lifeskim:mentionsumls-concept:C0439743lld:lifeskim
pubmed-article:9040837pubmed:issue4lld:pubmed
pubmed-article:9040837pubmed:dateCreated1997-3-17lld:pubmed
pubmed-article:9040837pubmed:abstractTextTo determine response rate and remission as well as survival times for dogs with multicentric lymphoma treated first with doxorubicin alone or in combination with asparaginase and then with cyclophosphamide, vincristine sulfate, and prednisone (CVP) and to identify prevalence of toxicoses associated with this protocol and factors associated with prognosis.lld:pubmed
pubmed-article:9040837pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9040837pubmed:languageenglld:pubmed
pubmed-article:9040837pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9040837pubmed:citationSubsetIMlld:pubmed
pubmed-article:9040837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9040837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9040837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9040837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9040837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9040837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9040837pubmed:statusMEDLINElld:pubmed
pubmed-article:9040837pubmed:monthFeblld:pubmed
pubmed-article:9040837pubmed:issn0003-1488lld:pubmed
pubmed-article:9040837pubmed:authorpubmed-author:OgilvieG KGKlld:pubmed
pubmed-article:9040837pubmed:authorpubmed-author:GetzyD MDMlld:pubmed
pubmed-article:9040837pubmed:authorpubmed-author:MallinckrodtC...lld:pubmed
pubmed-article:9040837pubmed:authorpubmed-author:ValeriusK DKDlld:pubmed
pubmed-article:9040837pubmed:issnTypePrintlld:pubmed
pubmed-article:9040837pubmed:day15lld:pubmed
pubmed-article:9040837pubmed:volume210lld:pubmed
pubmed-article:9040837pubmed:ownerNLMlld:pubmed
pubmed-article:9040837pubmed:authorsCompleteYlld:pubmed
pubmed-article:9040837pubmed:pagination512-6lld:pubmed
pubmed-article:9040837pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9040837pubmed:meshHeadingpubmed-meshheading:9040837-...lld:pubmed
pubmed-article:9040837pubmed:meshHeadingpubmed-meshheading:9040837-...lld:pubmed
pubmed-article:9040837pubmed:meshHeadingpubmed-meshheading:9040837-...lld:pubmed
pubmed-article:9040837pubmed:meshHeadingpubmed-meshheading:9040837-...lld:pubmed
pubmed-article:9040837pubmed:meshHeadingpubmed-meshheading:9040837-...lld:pubmed
pubmed-article:9040837pubmed:meshHeadingpubmed-meshheading:9040837-...lld:pubmed
pubmed-article:9040837pubmed:meshHeadingpubmed-meshheading:9040837-...lld:pubmed
pubmed-article:9040837pubmed:meshHeadingpubmed-meshheading:9040837-...lld:pubmed
pubmed-article:9040837pubmed:meshHeadingpubmed-meshheading:9040837-...lld:pubmed
pubmed-article:9040837pubmed:meshHeadingpubmed-meshheading:9040837-...lld:pubmed
pubmed-article:9040837pubmed:meshHeadingpubmed-meshheading:9040837-...lld:pubmed
pubmed-article:9040837pubmed:meshHeadingpubmed-meshheading:9040837-...lld:pubmed
pubmed-article:9040837pubmed:meshHeadingpubmed-meshheading:9040837-...lld:pubmed
pubmed-article:9040837pubmed:meshHeadingpubmed-meshheading:9040837-...lld:pubmed
pubmed-article:9040837pubmed:meshHeadingpubmed-meshheading:9040837-...lld:pubmed
pubmed-article:9040837pubmed:meshHeadingpubmed-meshheading:9040837-...lld:pubmed
pubmed-article:9040837pubmed:year1997lld:pubmed
pubmed-article:9040837pubmed:articleTitleDoxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).lld:pubmed
pubmed-article:9040837pubmed:affiliationDepartment of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins 80523, USA.lld:pubmed
pubmed-article:9040837pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9040837pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9040837lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9040837lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9040837lld:pubmed